Anuh Pharma Ltd
ANUHPHR
Company Profile
Business description
Anuh Pharma Ltd is an Indian company engaged in manufacturing and selling bulk drugs and chemicals. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, corticosteroids, and others. Geographically, the company generates maximum revenue from its domestic market and also exports its products to other countries.
Contact
Dr. Annie Besant Road
North Wing, 3-A, Shiv Sagar Estate
Worli
MumbaiMH400018
INDT: +91 2266227575
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
295
Stocks News & Analysis
stocks
ASX utility share downgraded as electricity prices fall
Falling electricity prices weigh on earnings outlook for utility provider.
stocks
Chart of the Week: AI market leader is now surprisingly cheap
This AI beneficiary may still be one of the market’s most compelling bargains.
stocks
Weekly earnings wrap: Rio Tinto leads the way
A closer look at the key earnings results from the first week of August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,452.00 | 42.10 | 0.45% |
| CAC 40 | 8,736.07 | 66.78 | 0.77% |
| DAX 40 | 26,196.40 | 70.10 | 0.27% |
| Dow JONES (US) | 54,313.22 | 35.90 | -0.07% |
| FTSE 100 | 10,873.77 | 14.53 | -0.13% |
| HKSE | 25,530.28 | 385.54 | -1.49% |
| NASDAQ | 26,441.01 | 77.57 | 0.29% |
| Nikkei 225 | 65,683.26 | 617.18 | -0.93% |
| NZX 50 Index | 13,958.06 | 39.12 | -0.28% |
| S&P 500 | 7,738.96 | 15.41 | 0.20% |
| S&P/ASX 200 | 9,271.60 | 41.80 | 0.45% |
| SSE Composite Index | 3,900.35 | 21.92 | 0.57% |